We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Computer-Designed Proteins: Could These Become a New Class of Drugs?

News   Sep 28, 2017 | Original story from the University of Washington

 
Computer-Designed Proteins: Could These Become a New Class of Drugs?

This is an artist impression of computer-designed mini protein binders targeting Influenza hemagglutinin. Many effectively bind and neutralize the virus. Image credit: Cognition Studio (Seattle) with assistance of Daniel-Adriano Silva and Lance Stewart.

 
 
 

RELATED ARTICLES

Transcriptic to Oversee Robotic Cloud Lab For Eli Lilly

News

Transcriptic announced today that it has entered into an agreement with Eli Lilly and Company whereby Lilly will license the Transcriptic Common Lab Environment to enable on-demand drug discovery operations at its San Diego Biotechnology Center.

READ MORE

Autoscribe Informatics Expands Distribution Network

News

Autoscribe Informatics, a specialist provider of Laboratory Information Management Systems (LIMS), has expanded its worldwide distribution network. Corporación Científica Venezolana, CA has been appointed to cover South America, while V*I*Production sp z.o.o. will represent Autoscribe in Germany and Poland.

READ MORE

Common Disease Mechanism for ALS and Frontotemporal Dementia

News

Findings suggest mutations leading to accumulation of RNA-binding proteins to blame for disease, and could offer route for early diagnosis

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE